Related Experiment Videos

Epidermal growth factor receptor expression in a retinoic acid-treated human melanoma cell line

Y Yongshan1, D M DeBauche, W S Stanley

  • 1Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston 29425.

Insights

Retinoic acid (RA) induced differentiation and reduced cloning capacity in metastatic melanoma cells (HXG-2). However, RA treatment did not alter epidermal growth factor (EGF) receptor gene expression or amplification, suggesting the EGF pathway is not involved.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Metastatic melanoma is an aggressive skin cancer.
  • Retinoic acid (RA) is a derivative of Vitamin A known to influence cell differentiation.
  • Epidermal Growth Factor (EGF) receptor signaling is implicated in some cancers, including melanoma.

Purpose of the Study:

  • To investigate the effects of retinoic acid (RA) on the metastatic melanoma cell line HXG-2.
  • To determine if RA-induced changes in HXG-2 cells involve the epidermal growth factor (EGF) receptor pathway.

Main Methods:

  • Treatment of HXG-2 cells with retinoic acid (RA).
  • Assay of cloning capacity in soft agar.
  • Slot blot hybridization to detect EGF receptor gene amplification.
  • RNA analysis and EGF receptor expression determination.

Main Results:

  • RA treatment induced morphologic differentiation and abolished soft agar cloning capacity in HXG-2 cells.
  • No evidence of EGF receptor gene amplification was found in HXG-2 cells compared to normal fibroblasts.
  • RA treatment did not significantly alter EGF receptor gene expression or protein levels.

Conclusions:

  • RA induces differentiation and reduces the transformation potential of HXG-2 melanoma cells.
  • The observed effects of RA are likely independent of the epidermal growth factor (EGF) receptor pathway.
  • RA may offer a therapeutic strategy for melanoma by targeting pathways other than EGF receptor signaling.

Related Concept Videos